News - Zydus Cadila


Current filters:

Zydus Cadila

Popular Filters

Depomed settlements with two Gralise ANDA filers


US specialty drugmaker Depomed has entered into settlement agreements with two of the three defendants…

DepomedGenericsGraliseIncepta PharmaceuticalsLegalNeurologicalNorth AmericaPatentsUSAZydus Cadila

Cadila net profit up by 82% in third-quarter


Indian drugmaker Cadila Healthcare posted a net profit of 1.86 billion rupees ($29.7 million), for the…

BiosimilarsCadila PharmaceuticalsFinancialGenericsResearchZydus Cadila

Cadila pulls out of operations in Japan

Cadila pulls out of operations in Japan


One of India’s largest pharmaceutical companies, Cadila Healthcare (also operating as Zydus Cadila),…

Asia-PacificFinancialIndiaPharmaceuticalZydus Cadila

Zydus Cadila settles Asacol patent litigation in USA


Zydus Cadila, one of India’s largest privately-held pharmaceuticals companies, and affiliate Zydus…

ActavisAsacol HDGastro-intestinalsGenericsNorth AmericaPatentsWarner ChilcottZydus Cadila

India’s Zydus Cadila posts 94% rise in 2nd-qtr net profit


For the second fiscal quarter ended September 30, 2013, Indian drugmaker Zydus Cadila’s net profit…

FinancialGenericsZydus Cadila

Zydus in deal with Pieris for novel Anticalin therapeutics


Indian drugmaker Zydus Cadila has entered into an alliance with privately-held German company Pieris…

Asia-PacificLicensingOncologyPharmaceuticalPieris AGPRS-110Zydus Cadila

India's Zydus and IDRI to develop new vaccine for deadly parasitic disease


India's fourth largest health care group Zydus and non-profit global health organization Infectious Disease…

Asia-PacificPharmaceuticalResearchVaccinesZydus Cadila

Zydus' diabetes drug Lipaglyn becomes India's first NCE to reach the market


Indian drugmaker Zydus Cadila today (June 5) made a breakthrough in its research efforts with Lipaglyn…

Asia-PacificDiabetesLipaglynPharmaceuticalRegulationZydus Cadila

Zydus Cadila's net profit up by 54% in fourth qtr


Indian drugmaker Zydus Cadila posted results for the fourth quarter ended March 31, 2013, showing that…

FinancialGenericsZydus Cadila

Zydus Cadila unit launches udenafil for erectile dysfunction in India


Zydus Urosciences, the specialty division of Indian drugmaker Zydus Cadila, is launching udenafil a next…

Asia-PacificDong-A PharmaceuticalsLicensingMarkets & MarketingMen's HealthPharmaceuticaludenafilUdzireZydemaZydus Cadila

Zydus Cadila third-quarter revenues up 20%


Indian drugmaker Zydus Cadila posted total revenue of 14.01 billion rupees ($287.7 million) for the third…

FinancialGenericsZydus Cadila

Zydus Cadila acquires Mumbai-based Biochem


Indian drug firm Zydus Cadila says it has acquired a 100% stake in Biochem, described as one of the top…

Antibiotics and Infectious diseasesAsia-PacificBiochemGenericsMergers & AcquisitionsZydus Cadila

Ranbaxy debuts generic Femara in UK, France and Romania; FDA OKs Zydus plant


India’s largest drugmaker, Ranbaxy Laboratories (RANB: BO) which is 64% owned by Japan’s Daiichi…

Asia-PacificEuropeFemaraGenericsMarkets & MarketingNovartisOncologyRanbaxy LaboratoriesRegulationZydus Cadila

Zydus Cadila 1st-qtr fiscal net profit jumps 15%


Indian drugmaker Zydus Cadila reported sales of 11.89 billion rupees ($175.2 million) for its fiscal…

FinancialGenericsZydus Cadila

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top